Indeed, increased CD4+ mediated production of IFNγ has previously been reported as a consequence of using liposome-DNA complexes as an adjuvant for genital herpes vaccines [37] and for delivery of a mycobacterial hsp65 DNA vaccine [38]. The gene discussed is IFNG; the disease is genital herpes.